consequences of glp 1 The promise and peril GLP-1 agonists: What we do (and don't) know as of August 2024 long-term effects of glp-1 medications

Analyst reports suggest that five of the top ten pharmaceutical firms face revenue exposure exceeding 50% of their current revenue from the current patent cliff

And leptin tells our body when its eaten enough food and takes away the feeling of hunger

Because it works gradually, spironolactone is usually best thought of as a maintenance medication rather than a quick rescue

Natural Products: Potential Source of DPP-IV Inhibitors. Current Protein & Peptide Science, vol

Similarly, the dual GLP-1R and GIP agonist tirzepatide promoted the intake of standard rodent chow at the expense of a high-fat diet in mice, suggesting a preferential shift toward less energy-dense foods (Geisler et al., 2023)